Sky Century Investment (SKYI) Cash from Operations Growth (1y) (2013 - 2026)
Sky Century Investment (SKYI) Cash from Operations Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 81.06% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 8.26% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -46.22% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 63.59% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 73.78% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 33.73% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 16.88% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | -198.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -198.53% |
| Feb 28, 2026 | 123.28% |
| Nov 30, 2025 | 42.64% |
| Aug 31, 2025 | -58.94% |
| May 31, 2025 | 1,120.19% |
| Feb 28, 2025 | 11.52% |
| Feb 28, 2014 | 2.88% |
| Nov 30, 2013 | -952.80% |
| Aug 31, 2013 | -2.50% |